Mode
Text Size
Log in / Sign up
Phase 4 Completed N=393 Randomized Quadruple-blind Treatment

Acetaminophen (APAP) +/- Oxycodone

Source: ClinicalTrials.gov NCT04122443 ↗
Enrolled (actual)
393
Serious AEs
0.0%
Results posted
Feb 2024
Primary outcomePrimary: Change in Pain Assessment — 2.9; 4.0 score on a scale
◆ Published Evidence
No publication linked

No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.

Summary

This is an emergency department based randomized study of oxycodone/ acetaminophen versus acetaminophen alone for patients with acute musculoskeletal pain refractory to ibuprofen

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Pain Assessment
2.9; 4.0
SECONDARY
Sustained Pain Relief
33; 43; 44; 34
SECONDARY
Adequacy of Analgesia
51; 59; 23; 17; 0; 0
SECONDARY
Satisfaction With Medication
41; 47; 22; 18; 10; 11
SECONDARY
Medication-related Adverse Events
7; 26

Eligibility Criteria

Inclusion Criteria

  • Acute musculoskeletal pain: Any pain attributable to muscles, bones, joints, tendons, ligaments or supporting structures, as determined by the clinical team, of 10 days duration or less. Prior to the onset of acute pain, patients cannot have experienced pain in the same body region during the prior six months
  • Pain has to be described as moderate or severe, when the patient is asked if the pain is mild, moderate or severe in intensity

Exclusion Criteria

  • Use of an non-steroidal anti-inflammatory drug within the previous six hours
  • Use of acetaminophen within the previous six hours
  • Use of an opioid within the previous ten days
  • Chronic pain, defined as any pain on >50% of days for at least 3 months prior to onset of acute pain
  • Gout
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04122443). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search